Shattering barriers toward clinically meaningful MSC therapies von Levy, Oren, Kuai, Rui, Siren, Erika M. J., Bhere, Deepak, Milton, Yuka, Nissar, Nabeel, De Biasio, Michael, Heinelt, Martina, Reeve, Brock, Abdi, Reza, Alturki, Meshael, Fallatah, Mohanad, Almalik, Abdulaziz, Alhasan, Ali H., Shah, Khalid, Karp, Jeffrey M.

Volltext

Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells von Bhere, Deepak, Choi, Sung Hugh, van de Donk, Pim, Hope, David, Gortzak, Kiki, Kunnummal, Amina, Khalsa, Jasneet, Revai Lechtich, Esther, Reinshagen, Clemens, Leon, Victoria, Nissar, Nabil, Bi, Wenya Linda, Feng, Cheng, Li, Hongbin, Zhang, Yu Shrike, Liang, Steven H., Vasdev, Neil, Essayed, Walid Ibn, Quevedo, Pablo Valdes, Golby, Alexandra, Banouni, Naima, Palagina, Anna, Abdi, Reza, Fury, Brian, Smirnakis, Stelios, Lowe, Alarice, Reeve, Brock, Hiller, Arthur, Chiocca, E. Antonio, Prestwich, Glenn, Wakimoto, Hiroaki, Bauer, Gerhard, Shah, Khalid

Volltext

The Global Cell Therapy Industry Continues to Rise during the Second and Third Quarters of 2012 von Mason, Chris, McCall, Mark J., Culme-Seymour, Emily J., Suthasan, Shalini, Edwards-Parton, Simon, Bonfiglio, Gregory A., Reeve, Brock C.

Volltext

Cell Therapy Companies Make Strong Progress from October 2012 to March 2013 Amid Mixed Stock Market Sentiment von Mason, Chris, Mason, Julian, Culme-Seymour, Emily J., Bonfiglio, Gregory A., Reeve, Brock C.

Volltext

The 3Rs of Cell Therapy von Caplan, Arnold I., Mason, Chris, Reeve, Brock

Volltext

The Impact of Market Volatility on the Cell Therapy Industry von Brindley, David A., Reeve, Brock C., Sahlman, William A., Bonfiglio, Greg A., Davie, Natasha L., Culme-Seymour, Emily J., Mason, Chris

Volltext

Promising Growth and Investment in the Cell Therapy Industry during the First Quarter of 2012 von Brindley, David A., Davie, Natasha L., Sahlman, William A., Bonfiglio, Gregory A., Culme-Seymour, Emily J., Reeve, Brock C., Mason, Chris

Volltext

An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol von Pettitt, David, Arshad, Zeeshaan, Davies, Benjamin, Smith, James, French, Anna, Cole, Doug, Bure, Kim, Dopson, Sue, DiGiusto, David, Karp, Jeff, Reeve, Brock, Barker, Richard, Holländer, Georg, Brindley, David

Volltext

A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies von Davies, Benjamin M, Smith, James, Rikabi, Sarah, Wartolowska, Karolina, Morrey, Mark, French, Anna, MacLaren, Robert, Williams, David, Bure, Kim, Pinedo-Villanueva, Rafael, Mathur, Anthony, Birchall, Martin, Snyder, Evan, Atala, Anthony, Reeve, Brock, Brindley, David

Volltext

Enabling Consistency in Pluripotent Stem Cell‐Derived Products for Research and Development and Clinical Applications Through Material Standards von French, Anna, Bravery, Christopher, Smith, James, Chandra, Amit, Archibald, Peter, Gold, Joseph D., Artzi, Natalie, Kim, Hae-Won, Barker, Richard W., Meissner, Alexander, Wu, Joseph C., Knowles, Jonathan C., Williams, David, García-Cardeña, Guillermo, Sipp, Doug, Oh, Steve, Loring, Jeanne F., Rao, Mahendra S., Reeve, Brock, Wall, Ivan, Carr, Andrew J., Bure, Kim, Stacey, Glyn, Karp, Jeffrey M., Snyder, Evan Y., Brindley, David A.

Volltext

Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study von Davies, Benjamin M, Rikabi, Sarah, French, Anna, Pinedo-Villanueva, Rafael, Morrey, Mark E, Wartolowska, Karolina, Judge, Andrew, MacLaren, Robert E, Mathur, Anthony, Williams, David J, Wall, Ivan, Birchall, Martin, Reeve, Brock, Atala, Anthony, Barker, Richard W, Cui, Zhanfeng, Furniss, Dominic, Bure, Kim, Snyder, Evan Y, Karp, Jeffrey M, Price, Andrew, Carr, Andrew, Brindley, David A

Volltext

The global intellectual property landscape of induced pluripotent stem cell technologies von Roberts, MacKenna, Wall, Ivan B, Bingham, Ian, Icely, Dominic, Reeve, Brock, Bure, Kim, French, Anna, Brindley, David A

Volltext

Bioprocess decision support tool for scalable manufacture of extracellular vesicles von Ng, Kelvin S., Smith, James A., McAteer, Matthew P., Mead, Benjamin E., Ware, Jamie, Jackson, Felix O., Carter, Alison, Ferreira, Lino, Bure, Kim, Rowley, Jon A., Reeve, Brock, Brindley, David A., Karp, Jeffrey M.

Volltext

The 3Rs of Cell Therapy von Caplan, Arnold I, Mason, Chris, Reeve, Brock

Volltext

Pharmaceutical industry: Investors unfazed by drug-patent expiry von Brindley, David, Reeve, Brock, Mason, Chris

Volltext

Investors unfazed by drug-patent expiry von Brindley, David, Reeve, Brock, Mason, Chris

Volltext

Generating iPSCs: Translating Cell Reprogramming Science into Scalable and Robust Biomanufacturing Strategies von Silva, Marli, Daheron, Laurence, Hurley, Hannah, Bure, Kim, Barker, Richard, Carr, Andrew J., Williams, David, Kim, Hae-Won, French, Anna, Coffey, Pete J., Cooper-White, Justin J., Reeve, Brock, Rao, Mahendra, Snyder, Evan Y., Ng, Kelvin S., Mead, Benjamin E., Smith, James A., Karp, Jeffrey M., Brindley, David A., Wall, Ivan

Volltext

Global strategic partnerships in regenerative medicine von French, Anna, Suh, Jane Y, Suh, Carol Y, Rubin, Lee, Barker, Richard, Bure, Kim, Reeve, Brock, Brindley, David A

Volltext

The global intellectual property landscape of induced pluripotent stem cell technologies: will freedom to research and innovate be restricted as the induced pluripotent stem cell f... von Roberts, MacKenna, Wall, Ivan B, Bingham, Ian, Icely, Dominic, Reeve, Brock, Bure, Kim, French, Anna, Brindley, David A

Volltext

Global strategic partnerships in regenerative medicine: Next Generation Therapeutics von FRENCH, Anna, SUH, Jane Y, SUH, Carol Y, RUBIN, Lee, BARKER, Richard, BURE, Kim, REEVE, Brock, BRINDLEY, David A

Volltext